Table 1 Analysis of the differences in characteristics between IDUr and n-IDUr.

From: Explainable illicit drug abuse prediction using hematological differences

Variables

Non-IDU (n=248)

IDU (n=244)

P value

Cl, mmol/L

103.5 [100.6–105.3]

16.0 [14.9–17.4]

< 0.001

RBP, ug/ml

33.8 [26.4–40.6]

25.0 [17.2–32.1]

< 0.001

eGFR, mL/min

92.6 [76.1–106.5]

73.72 [38.7–89.6]

< 0.001

Folate, nmol/L

5.8 [4.1–8.6]

3.3 [2.2–4.4]

< 0.001

CHOL, mmol/L

4.7 [4.1–5.4]

3.9 [3.4–4.7]

< 0.001

BHB, mmol/L

0.06 [0.03–0.16]

0.3 [0.18–0.5]

< 0.001

PCT, \(\%\)

0.25 [0.21–0.29]

0.2 [0.16–0.24]

< 0.001

HFLC=0, \(\%\)

53(21.4)

244(100)

< 0.001

T3, ng/ml

1.02 [0.88–1.16]

1.20 [0.99–1.36]

< 0.001

NRBC=0, \(\%\)

60(24.2)

12(4.9)

< 0.001

CHE, U/L

9.1 [7.7–10.4]

8.1 [6.4–9.5]

< 0.001

ApoB, g/L

0.92 [0.74–1.11]

0.75 [0.62–0.93]

< 0.001

HCO3, mmol/L

19.1 [17.6–20.4]

17.9 [16.3–19.1]

< 0.001

PLT, \(10^{9}\)/L

238 [195–282]

197 [146–243]

< 0.001

CYSC, mg/L

0.89 [0.75–1.04]

0.98 [0.85–1.48]

< 0.001

UA, mmol/L

362.7 [301.8–450.5]

335.4 [233.8–398.2]

< 0.001

Zn, umol/L

11.2 [9.2–12.7]

9.8 [7.2–12.4]

< 0.001

ALB, g/L

48.7 [46.3–51.2]

47.0 [44.9–48.9]

< 0.001

LDL-C, mmol/L

2.77 [2.33–3.40]

2.39 [1.81–2.97]

< 0.001

TP, g/L

76.3 [73.2–78.9]

74.9 [71.9–78.7]

< 0.001

ApoA−1, g/L

1.40 [1.23–1.53]

1.27 [1.16–1.42]

< 0.001

HCY, umol/L

16.7 [14.0–20.1]

18.5 [15.2–26.4]

< 0.001

IgA, g/L

2.56 [1.91–3.19]

2.26 [1.65–2.80]

< 0.001

FRUC, umol/L

264.5 [245.6–279.0]

250.7 [232.4–266.9]

< 0.001

HbA1c, \(\%\)

5.9 [5.6–6.2]

5.8 [5.6–6.1]

< 0.001

PDW, \(\%\)

12.2 [11.2–13.6]

11.5 [10.4–12.8]

< 0.001

P-LCR, \(\%\)

29.7 [24.4–34.6]

26.7 [22.1–32.5]

< 0.001

VitB12, pmol/L

372 [274–521]

248 [169–348]

< 0.001

  1. Continuous values are shown as median [interquartile range], categorical values are shown as number [percentage], and P-values were calculated using an independent sample T test and sorted from small to large